Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “INTEGRATED BIOTHERAPEUTIC VACCINES, INC.”

2 pharma patents match "INTEGRATED BIOTHERAPEUTIC VACCINES, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 2 pharmaceutical patents matching "INTEGRATED BIOTHERAPEUTIC VACCINES, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2 results for “INTEGRATED BIOTHERAPEUTIC VACCINES, INC.” · 30,257 patents in full index Clear search

  1. US 11421021

    Immunogenic compositions comprising Staphylococcus aureus leukocidin LukA and LukB derived polypeptides

    INTEGRATED BIOTHERAPEUTIC VACCINES, INC. · Granted Aug 23, 2022 · Expires Aug 18, 2042

    granted

  2. US 11260120

    Immunogenic composition comprising a fusion peptide derived from superantigen toxoids

    INTEGRATED BIOTHERAPEUTIC VACCINES, INC. · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.